The US Patent and Trademark Office (USPTO) will issue Patent No. 8,340,916 to Sequenom for its application covering methods of detecting fetal aneuploidy. The patent, which will be issued on 25 December 2012, covers claims related to ...
Tags: Sequenom, US patent, fetal aneuploidy, USPTO
Sequenom's European licensing partner LifeCodexx has launched its Praena test service in more than 70 prenatal clinics and hospitals in Germany, Austria, Liechtenstein and Switzerland following the CE mark approval. LifeCodexx CEO Michael ...
Tags: Praena test, LifeCodexx, Sequenom